News & Events

Take a behind-the-scenes look at how researchers study lung cancer. Join lung cancer researcher Triparna Sen, PhD, as she digs into what’s known about how EGFR-positive NSCLC cells transform into SCLC to escape targeted therapy treatment. SCLC transformation is a common resistance mechanism for multiple types of NSCLC, including EGFR, ALK, and RET. This Facebook Live event is hosted by Amy Moore, PhD, LUNGevity’s Vice President of Global Engagements and Patient Partnerships. Dr. Sen is Co-…

Brain metastases are known to occur in approximately 25% of patients diagnosed with lung cancer. This webinar dives into the details of brain metastasis in lung cancer to explore their signs and symptoms. It also includes a discussion of treatment considerations. Through this webinar, you will learn to: Understand how brain metastasis occurs Keep an eye out for signs & symptoms of brain mets Understand treatment options and management techniques This webinar was created in partnership…

Pulmonary rehab expert Debbie Koehl, MS, RRT-NPS, AE-C, FAARC, speaks to LUNGevity's Survivorship Navigator, Kristi Griffith, to explain what pulmonary rehabilitation is, explore the benefits of pulmonary rehabilitation, and gain key insights about how to obtain pulmonary rehabilitation for yourself or a loved one. The discussion is followed by an informal Q&A with other lung cancer survivors. This recording was made during one of LUNGevity Foundation's Virtual Meetups -- a free resource…

In this video, nurse practitioner Lauren Welch, MSN, NP-C, AOCNP, from the Sarah Cannon Research Institute at Tennessee Oncology offers a quick review of pneumonitis - a common side effect of some lung cancer treatments. Survivors and caregivers can learn: What is pneumonitis? What causes it? How is it treated? What symptoms should we look out for?

LUNGevity's Upal Basu Roy, PhD, MPH, Executive Director of Research, interviewed Hilary Hammell (RETpositive) and Dr. Alexandre Reuben (MD Anderson Cancer Center) about an exciting project on using the immune system to treat RET-positive lung cancer. This project is being funded by the RETpositive patient group. This interview was live on Facebook on October 18; watch the video here.

Every fall, the lung cancer community gathers to raise awareness for this disease and stand together – unified and strong. November is Lung Cancer Awareness Month – a time to come together to celebrate the strength of the lung cancer community. A great way to get involved in raising awareness about lung cancer is by joining us on Saturday, November 5 for our nationwide walk - Breathe Deep TOGETHER  presented by Amgen. Thousands of people from across the country, coming together in a singular…

Whether you are newly diagnosed or a long-term survivor, LUNGevity offers lung cancer support and survivorship services to address your unique needs. LUNGevity's services are designed to help you feel supported, informed, and empowered to be an active decision-maker in your treatment process and live well with the disease.   LUNGevity's survivorship services are free and feature programs for survivors, caregivers, and family members. Read on to learn about our offerings and how you can access…

Lung cancer survivor Jill Feldman joins radiation therapy experts Drs. Drew Moghanaki and Kristin Higgins to provide an overview of radiation therapy – including discussions of when this treatment is recommended, how the treatment is administered, and which side effects are most common.

Navigating a lung cancer diagnosis can feel overwhelming not only to the patient but to their caregiver as well. It’s normal to feel lost or confused and not know where to start or what resources to ask for. Because a cancer diagnosis is a family diagnosis, LUNGevity wants caregivers to know they don’t have to go through it alone. There are resources available to help caregivers take care of their loved ones as well as themselves. Here are 5 important caregiver resources to help with your loved…

For decades, lung cancer was synonymous with low survival rates, limited treatment options, and poor quality of life for those living with the disease. Each year, more than 236,000 people in the US are diagnosed with lung cancer. The high incidence of lung cancer means scientific research into new therapies is critical, both for current survivors and those who will be diagnosed in the future. Thankfully, the landscape of lung cancer is changing for the better. Due to progress in research and…